Costs associated with outpatient, emergency room and inpatient care for migraine in the USA

Cephalalgia

Volumn 31, Issue 15, 2011, Pages 1570-1575

  Insinga, Ralph P ^a   Ng Mak, Daisy S ^a   Hanson, Mary E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

direct healthcare costs; emergency room visits; inpatient hospitalization; Migraine; outpatient visits

Indexed keywords

ANALGESIC AGENT; KETOROLAC; PETHIDINE; PROMETHAZINE;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST OF ILLNESS; EMERGENCY CARE; EMERGENCY PATIENT; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; OUTPATIENT CARE; RETROSPECTIVE STUDY; UNITED STATES;

AMBULATORY CARE; EMERGENCY MEDICAL SERVICES; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REPORTING; MIGRAINE DISORDERS; PREVALENCE; UNITED STATES;

EID: 81855187116     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411425960     Document Type: Article

References (22)

1. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 ; 68: 343-349 (Pubitemid 46184209)
2. Edmeads J, Findlay H, Tugwell P, et al. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci. 1993 ; 20: 131-137 (Pubitemid 23212865)
3. Dueland AN, Leira R, Cabelli ST. The impact of migraine on psychological well-being of young women and their communication with physicians about migraine: a multinational study. Curr Med Res Opin. 2005 ; 21: 1297-1305 (Pubitemid 41140734)
4. Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999 ; 159: 813-818 (Pubitemid 29200307)
5. Gerth WC, Carides GW, Dasbach EJ, et al. The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics. 2001 ; 19: 197-206 (Pubitemid 32176472)
6. Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees with migraine. Headache. 2008 ; 48: 553-563 (Pubitemid 351464682)
7. Stang PE, Crown WH, Bizier R, et al. The family impact and costs of migraine. Am J Manag Care. 2004 ; 10: 313-320 (Pubitemid 38623522)
8. Machlin S, Miller E Health service use and expenses for migraines and other headaches, 2002-03 (average annual estimates). Rockville, MD: ; 2006 :
9. Hawkins K, Rupnow M, Wang S. Direct cost burden of migraine among members of US employers. Value Health. 2006 ; 9: A85 - A85
10. Yu J, Goodman MJ, Oderda GM. Economic evaluation of pharmacotherapy of migraine pain: a review of the literature. J Pain Palliat Care Pharmacother. 2009 ; 23: 396-408
11. Bureau of Labor Statistics UDoL: Consumer Price Index-All Urban Consumers, Medical Care. 2010.
12. U.S. Census Bureau: Resident population projections by sex and age 2010 to 2050. 2010.
13. Buse D, Pearlman S, Reed M, et al. Opioid use and dependence among persons with episodic migraine in the US population: Results of the American migraine prevalence and prevention (AMPP) study [abstract]. Proceedings of the 53rd Annual Scientific Meeting of the American Headache Society 2011; June 2-4, 2011.
14. Agency for Healthcare Research and Quality USDoHaHS. National and regional estimates on hospital use for all patients HCUP Nationwide Inpatient Sample (NIS). 2008.
15. Paramore LC, Ciuryla V, Ciesla G, et al. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics. 2004 ; 22: 275-284 (Pubitemid 38553698)
16. Maizels M, Saenz V, Wirjo J. Impact of a group-based model of disease management for headache. Headache. 2003 ; 43: 621-627 (Pubitemid 36828798)
17. Cooke LJ, Becker WJ. Migraine prevalence, treatment and impact: the Canadian women and migraine study. Can J Neurol Sci. 2010 ; 37: 580-587
18. Duncan CW, Watson DP, Stein A. Diagnosis and management of headache in adults: summary of SIGN guideline. BMJ. 2008 ; 337: a2329 - a2329
19. Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004 ; 62: 788-790 (Pubitemid 38298959)
20. Katic BJ, Rajagopalan S, Ho TW, et al. Triptan persistency among newly initiated users in a pharmacy claims database. Cephalalgia. 2011 ; 31: 488-500
21. Ifergane G, Wirguin I, Shvartzman P. Triptans-why once?. Headache. 2006 ; 46: 1261-1263
22. Panconesi A, Pavone E, Franchini M, et al. Triptans: low utilization and high turnover in the general population. Cephalalgia. 2010 ; 30: 576-581